OBJECTIVE: Growth factor and cell-based angiogenesis are attractive therapeutic options for diabetic patients with end-stage coronary disease. Reduced collateral vessel formation observed in diabetes is associated with increased expression of anti-angiogenic proteins, angiostatin and endostatin. The aim of this study was to determine the effects of insulin treatment on the diabetic angiogenic response to chronic myocardial ischemia. METHODS: Yucatan miniswine were treated with alloxan (pancreatic beta-cell specific toxin, 150 mg/kg) and divided into two groups. In the diabetic group (DM, n = 8), blood glucose levels were kept greater than 250 mg/dL, and in the insulin-treated group (IDM, n = 6), intramuscular insulin was administered daily to keep blood glucose less than 150 mg/dL. A third group of age-matched swine served as nondiabetic controls (ND; n = 8). Eight weeks later, all animals underwent circumflex artery ameroid constrictor placement to induce chronic ischemia. Myocardial perfusion was assessed at 3 and 7 weeks after ameroid placement using microspheres. Microvascular function, capillary density, and myocardial expression of anti-angiogenic mediators were evaluated. RESULTS: Diabetic animals exhibited significant impairments in endothelium-dependent microvessel relaxation to adenosine diphosphate and substance P, which were reversed in insulin-treated animals. Collateral-dependent perfusion in the ischemic circumflex territory, which was profoundly reduced in diabetic animals (-0.18 +/- 0.02 vs +0.23 +/- 0.07 mL . min(-1) . g(-1); P < .001), improved significantly with insulin treatment (0.12 +/- 0.05 mL . min(-1) . g(-1); P < .01). Myocardial expression of anti-angiogenic proteins, angiostatin and endostatin, showing a 4.3- and 3.6-fold increase in diabetic animals respectively (both P < .01 vs ND), was markedly reduced in insulin-treated animals (2.3- and 1.8-fold vs ND; both P < .01). CONCLUSIONS: Insulin treatment successfully reversed diabetic coronary endothelial dysfunction and significantly improved the endogenous angiogenic response. These pro-angiogenic effects may be mediated through downregulation of anti-angiogenic mediators. Insulin therapy appears to be a promising modality to enhance the angiogenic response in diabetic patients.
OBJECTIVE: Growth factor and cell-based angiogenesis are attractive therapeutic options for diabeticpatients with end-stage coronary disease. Reduced collateral vessel formation observed in diabetes is associated with increased expression of anti-angiogenic proteins, angiostatin and endostatin. The aim of this study was to determine the effects of insulin treatment on the diabetic angiogenic response to chronic myocardial ischemia. METHODS: Yucatan miniswine were treated with alloxan (pancreatic beta-cell specific toxin, 150 mg/kg) and divided into two groups. In the diabetic group (DM, n = 8), blood glucose levels were kept greater than 250 mg/dL, and in the insulin-treated group (IDM, n = 6), intramuscular insulin was administered daily to keep blood glucose less than 150 mg/dL. A third group of age-matched swine served as nondiabetic controls (ND; n = 8). Eight weeks later, all animals underwent circumflex artery ameroid constrictor placement to induce chronic ischemia. Myocardial perfusion was assessed at 3 and 7 weeks after ameroid placement using microspheres. Microvascular function, capillary density, and myocardial expression of anti-angiogenic mediators were evaluated. RESULTS:Diabetic animals exhibited significant impairments in endothelium-dependent microvessel relaxation to adenosine diphosphate and substance P, which were reversed in insulin-treated animals. Collateral-dependent perfusion in the ischemic circumflex territory, which was profoundly reduced in diabetic animals (-0.18 +/- 0.02 vs +0.23 +/- 0.07 mL . min(-1) . g(-1); P < .001), improved significantly with insulin treatment (0.12 +/- 0.05 mL . min(-1) . g(-1); P < .01). Myocardial expression of anti-angiogenic proteins, angiostatin and endostatin, showing a 4.3- and 3.6-fold increase in diabetic animals respectively (both P < .01 vs ND), was markedly reduced in insulin-treated animals (2.3- and 1.8-fold vs ND; both P < .01). CONCLUSIONS:Insulin treatment successfully reversed diabetic coronary endothelial dysfunction and significantly improved the endogenous angiogenic response. These pro-angiogenic effects may be mediated through downregulation of anti-angiogenic mediators. Insulin therapy appears to be a promising modality to enhance the angiogenic response in diabeticpatients.
Authors: M Simons; R O Bonow; N A Chronos; D J Cohen; F J Giordano; H K Hammond; R J Laham; W Li; M Pike; F W Sellke; T J Stegmann; J E Udelson; T K Rosengart Journal: Circulation Date: 2000-09-12 Impact factor: 29.690
Authors: Marc Ruel; Gui Fu Wu; Tanveer A Khan; Pierre Voisine; Cesario Bianchi; Jianyi Li; Jian Li; Roger J Laham; Frank W Sellke Journal: Circulation Date: 2003-09-09 Impact factor: 29.690
Authors: LiFeng Zhang; Andrew Zalewski; Yuchuan Liu; Tomasz Mazurek; Scott Cowan; Jack L Martin; Susanna M Hofmann; Helen Vlassara; Yi Shi Journal: Circulation Date: 2003-07-14 Impact factor: 29.690
Authors: Dorothee Weihrauch; Nicole L Lohr; Boris Mraovic; Lynda M Ludwig; William M Chilian; Paul S Pagel; David C Warltier; Judy R Kersten Journal: Circulation Date: 2004-05-10 Impact factor: 29.690
Authors: Pierre Voisine; Cesario Bianchi; Marc Ruel; Tamer Malik; Audrey Rosinberg; Jun Feng; Tanveer A Khan; Shu-Hua Xu; Jennifer Sandmeyer; Roger J Laham; Frank W Sellke Journal: Surgery Date: 2004-08 Impact factor: 3.982
Authors: Munir Boodhwani; Neel R Sodha; Shigetoshi Mieno; Shu-Hua Xu; Jun Feng; Basel Ramlawi; Richard T Clements; Frank W Sellke Journal: Circulation Date: 2007-09-11 Impact factor: 29.690
Authors: Brittany A Potz; Ashraf A Sabe; Nassrene Y Elmadhun; Richard T Clements; M Ruhul Abid; Neel R Sodha; Frank W Sellke Journal: J Thorac Cardiovasc Surg Date: 2016-11-16 Impact factor: 5.209
Authors: Antonio D Lassaletta; Louis M Chu; Michael P Robich; Nassrene Y Elmadhun; Jun Feng; Thomas A Burgess; Roger J Laham; Michael Sturek; Frank W Sellke Journal: Basic Res Cardiol Date: 2012-01-10 Impact factor: 17.165
Authors: Neel R Sodha; Richard T Clements; Munir Boodhwani; Shu-Hua Xu; Roger J Laham; Cesario Bianchi; Frank W Sellke Journal: Am J Physiol Heart Circ Physiol Date: 2008-12-12 Impact factor: 4.733
Authors: Munir Boodhwani; Pierre Voisine; Marc Ruel; Neel R Sodha; Jun Feng; Shu-Hua Xu; Cesario Bianchi; Frank W Sellke Journal: Eur J Cardiothorac Surg Date: 2008-01-16 Impact factor: 4.191
Authors: Mohamed Sabra; Catherine Karbasiafshar; Ahmed Aboulgheit; Sidharth Raj; M Ruhul Abid; Frank W Sellke Journal: Int J Mol Sci Date: 2021-04-02 Impact factor: 5.923